As defined, the season begins in the 36th epidemiological week, ending the 35th week of the following year. Since approval for laninamivir and peramivir was in 2010, we ignored data for periods before 2010.
Estimated number of 10–19-year-old patients prescribed neuraminidase inhibitors each season (million cases).